Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Alnylam Pharmaceuticals (ALNY)
Technical Analysis Report for USA stock ALNY Alnylam Pharmaceuticals. Dated: 27 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ALNY Alnylam Pharmaceuticals then click here. or read Experts views on Alnylam Pharmaceuticals or Forecast & share price targets of Alnylam Pharmaceuticals
Alnylam Pharmaceuticals Opened at 236.56 and Closed at: 236.56, which is -1.03% of previous session's close. It moved within a range of 230.46 and 238.00
The session was a Neutral session with an average volume of 1293500, which is 13.71% of previous session's volumes.
- There is some positive change in the short term trend, but its too soon to jump onto conclusions.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
A Golden cross was found 3 days back on short term averages
Support for tomorrow is 232.79 and resistance for tomorrow is 240.33
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 232.01, 227.47 resistance for tomorrow's hourly charts is 239.55, 242.55
10 Day SMA for Alnylam Pharmaceuticals (ALNY) is 234.17 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Alnylam Pharmaceuticals (ALNY) is 226.99 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Alnylam Pharmaceuticals (ALNY) is 262.62 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 281.83 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Alnylam Pharmaceuticals is 326.13 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Alnylam Pharmaceuticals is at 226.99 and 200 DMA is at 326.13, while 50 DMA and 100 DMA are at 262.62 and 281.83 respectively
Alnylam Pharmaceuticals (ALNY) moving average of 20 SMA is at 226.99 and 20 EMA is at 237.35
| Date | Closing Price | 20 SMA | 20 EMA |
| 27 Thu Aug | 236.56 | 226.99 | 237.35 |
| 26 Wed Aug | 239.00 | 225.44 | 237.43 |
| 25 Tue Aug | 240.08 | 227.82 | 237.27 |
| 24 Mon Aug | 236.01 | 230.24 | 236.97 |
| 21 Fri Aug | 236.22 | 232.36 | 237.07 |
| 20 Thu Aug | 229.30 | 234.13 | 237.16 |
Alnylam Pharmaceuticals (ALNY) moving average of 50 SMA is at 262.62 and 50 EMA is at 255.31
| Date | Closing Price | 50 SMA | 50 EMA |
| 27 Thu Aug | 236.56 | 262.62 | 255.31 |
| 26 Wed Aug | 239.00 | 263.54 | 256.08 |
| 25 Tue Aug | 240.08 | 264.4 | 256.78 |
| 24 Mon Aug | 236.01 | 265.36 | 257.46 |
| 21 Fri Aug | 236.22 | 266.29 | 258.34 |
| 20 Thu Aug | 229.30 | 267.36 | 259.24 |
Alnylam Pharmaceuticals (ALNY) moving average of 100 SMA is at 281.83 and 100 EMA is at 278.69
| Date | Closing Price | 100 SMA | 100 EMA |
| 27 Thu Aug | 236.56 | 281.83 | 278.69 |
| 26 Wed Aug | 239.00 | 282.74 | 279.54 |
| 25 Tue Aug | 240.08 | 283.55 | 280.36 |
| 24 Mon Aug | 236.01 | 284.45 | 281.17 |
| 21 Fri Aug | 236.22 | 285.28 | 282.08 |
| 20 Thu Aug | 229.30 | 286.2 | 283.01 |
Alnylam Pharmaceuticals (ALNY) moving average of 200 SMA is at 326.13 and 200 EMA is at 302.36
| Date | Closing Price | 200 SMA | 200 EMA |
| 27 Thu Aug | 236.56 | 326.13 | 302.36 |
| 26 Wed Aug | 239.00 | 327.15 | 303.02 |
| 25 Tue Aug | 240.08 | 328.17 | 303.67 |
| 24 Mon Aug | 236.01 | 329.17 | 304.31 |
| 21 Fri Aug | 236.22 | 330.17 | 305 |
| 20 Thu Aug | 229.30 | 331.1 | 305.69 |
Alnylam Pharmaceuticals has performed better than Johnson Johnson in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Humana Inc in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Abbott Laboratories in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Rhythm Pharmaceuticals in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Pavmed Inc in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Organogenesis Holdings in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Opko Health in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Medicinova Inc in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Meiragtx Holdings has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Meiragtx Holdings, about 4.84% more returns!
Moleculin Biotech has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Moleculin Biotech, about 57.41% more returns!
Alnylam Pharmaceuticals has performed better than Livanova Plc in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Atyr Pharma has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Atyr Pharma, about 78.05% more returns!
Kura Oncology has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Kura Oncology, about 31.19% more returns!
Alnylam Pharmaceuticals has performed better than Kala Pharmaceuticals in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Helius Medical has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Helius Medical, about 32.18% more returns!
Alnylam Pharmaceuticals has performed better than Gossamer Bio in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Fulgent Genetics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Fulgent Genetics, about 5.45% more returns!
Alnylam Pharmaceuticals has performed better than Eloxx Pharmaceuticals in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Array Biopharma in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals Technical analysis of indicators
Price action analysis of Alnylam Pharmaceuticals (ALNY) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Alnylam Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Alnylam Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Alnylam Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Alnylam Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Alnylam Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 233.87 and Alnylam Pharmaceuticals ALNY stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Alnylam Pharmaceuticals ALNY stock. Volume based technical analysis of Alnylam Pharmaceuticals ALNY stock is negative.
Alnylam Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ALNY Alnylam Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ALNY Experts View which covers a lot of information including buying and selling signals
ALNY future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Alnylam Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


